天天彩票投注


WHITE-C
European Pharmacopoeia quality standards, genetically engineered drug with clinical verification for nearly 20 years

As a product with advanced American technology and the GMP conformity , recombinant Human Granulocyte Colony-Stimulating Factor has been clinically used for nearly twenty years since it was first available in 1999. Its export volume ranks the forefront of all congeneric products in domestic market. The strict quality internal enterprise standards has made Recombinant Human Granulocyte Colony-Stimulating Factor meet the quality requirements of both Chinese Pharmacopoeia and European Pharmacopoeia.

 

In 2002, White-C won China's high-quality product certificate issued by the Association technologie Nouvelle de France and was classified as recommended product for the EU market by the China Council for the Promotion of International Trade Department of Media Press and the Association technologie Nouvelle de France.

Product Manual

download

Please read the instructions carefully and use them under the guidance of a physician

[NAME]

Generic Name:Recombinant Human Granulocyte Colony-Stimulating Factor Injection

Brand Name:WHITE-C

Chinese Pinyin:Chongzu Ren Lixibao Cijiyinzi Zhusheye

 

[COMPOSITION]

Recombinant Human Granulocyte Colony-Stimulating Factor.

 

[PROPERTIES]

Colorless transparent liquid.

 

[INDICATION]

Prevent neutropenia caused by cancer chemotherapy;When cancer patients use chemotherapy which can cause myelosuppression,especially after the serious bone marrow deprived chemotherapy,the injection of this medicine will help preventing neutropenia from happening,relief the degree of neutropenia,shorten the last duration of neutropenia and speed up the recovery of granulocyte to reduce the risk of concurrent infection and fever.

 

[SPECIFICATION]

(1)75μg/0.5ml/ vial (4.5×106IU/0.5ml/ vial)

(2)150μg/0.5ml/ vial (9.0×106IU/0.5ml/ vial)

(3)300μg/1ml/ vial (1.8×107IU/1ml/ vial)

 

[ADMINISTRATION AND DOSAGE]

Tumor treatment

Used for neutropenia caused by cancer chemotherapy. When an adult patient began to use chemotherapy, and his/her neutrophile granulocyte reduce to 1000/mm3 (white blood cell count 2000/mm3) or below, use hypodermic injection or intravenous injection of this medicine for 2~5μg/kg once a day from the beginning of chemotherapy. When a children patient began to use chemotherapy, and his/her neutrophile granulocyte reduce to 500/mm3 (white blood cell count 1000/mm3) or below, use hypodermic injection or intravenous injection of this medicine for 2~5μg/kg once a day from the beginning of chemotherapy. When the neutrophile granulocyte rise again to 5000/mm3 (white blood cell count 10000/mm3) or above, stop the injection.

Leukemia treatment

Used for neutropenia caused by acute leukemia. When the white cell count of leukemia patient is less than 1000/mm3 after chemotherapy, and myeloblast in bone marrow decrease significantly and is no found in peripheral blood, use hypodermic injection or intravenous injection of this medicine for 2~5μg/kg once a day for adult patient, and 2μg/kg once a day for children patient. When the neutrophile granulocyte rise again to 5000/mm3 (white blood cell count 10000/mm3) or above, stop the medicine.

 

[ADVERSE REACTION]

1. Musculoskeletal system: muscle pain, bone pain, low back pain, chest pain happens occasionally.

2. Digestive System: inappetence happens occasionally, or liver AST, ALT increase.

3. Others: someone will have fever, headache, lacking in strength, skin rash, ALP, LDH increase.

4. Very few people will have shock, interstitial pneumonia, adult respiratory distress syndrome, immature neutrophil increase.

 

[CONTRAINDICATIONS]

1. Contraindicated in patients who have allergies to recombinant human granulocyte colony-stimulating factor and other preparations of E.coli expression.

2. Contraindicated in patients who have serious dysfunction of liver, kidney, heart or lung.

3. Contraindicated in patients who have myelomatosis and there is no remarkable reduction of immature granulocytes in bone marrow or the myelomatosis patients who have immature granulocytes found in peripheral blood.

 

[STORAGE]

2-8℃, keep in dark for storage and transportation

 

[PACKAGE]

1. Pharmaceutical glass penicillin bottle,1 vial /box.

2. Prefilled syringe,1 vial /box.

 

[PERIOD OF VALIDITY]

Penicillin bottle,30 months

Prefilled,24 months

 

[MANUFACUTURER]

Company Name:Shandong Kexing Bioproducts Co.,Ltd.

Production Address:No.2666, Chuangye Road, Mingshui Development Zone, Zhangqiu, Shandong, China

Zip Cod:250200

Telephone:(0531)83326820;800-8304545

Fax:0755-26632044

Website:http://www.sdkexing.cn

International Business

Continue to understand >